We therefore tested the effect of the three domains of IGFBP-5 on tumor growth and demonstrated that the C-terminal domain had a tumor suppressive function and that its overexpression inhibited VEGF-A expression and the Akt/ERK–NF-kB signaling pathway. This evidence concerns the gene IGFBP5 and neoplasm.